1-2 of 2
Natalie Reizine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Structurally-oriented classification of FOXA1 alterations identifies prostate cancers with opposing clinical outcomes and distinct molecular and immunologic subtypes

Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye, David Moline, Mark G. Evans, Andrew Elliott, Rachel Passow, Christine Luo, Emily John, Nishant Gandhi, Rana R. McKay, Elisabeth I. Heath, Chadi Nabhan, Natalie Reizine, Jacob J. Orme, Josep M. Domingo Domenech, Oliver Sartor, Sylvan C. Baca, Scott M. Dehm, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res (2025)
https://doi.org/10.1158/1078-0432.CCR-24-3471
Published: 02 January 2025
View article titled, Structurally-oriented classification of <em>FOXA1</em> alterations identifies prostate cancers with opposing clinical outcomes and distinct molecular and immunologic subtypes
Open the PDF for Structurally-oriented classification of <em>FOXA1</em> alterations identifies prostate cancers with opposing clinical outcomes and distinct molecular and immunologic subtypes in another window
Includes: Supplementary data
Journal Articles

Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy

Katherine I. Zhou, Bryan Peterson, Anthony Serritella, Joseph Thomas, Natalie Reizine, Stephanie Moya, Carol Tan, Yan Wang, Daniel V.T. Catenacci
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (24): 6453–6463.
https://doi.org/10.1158/1078-0432.CCR-20-2085
Published: 15 December 2020
View article titled, Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy
Open the PDF for Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy in another window
Includes: Supplementary data